首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Comparison of GP5+/6+-PCR and SPF10-Line Blot Assays for Detection of High-Risk Human Papillomavirus in Samples from Women with Normal Cytology Results Who Develop Grade 3 Cervical Intraepithelial Neoplasia
【2h】

Comparison of GP5+/6+-PCR and SPF10-Line Blot Assays for Detection of High-Risk Human Papillomavirus in Samples from Women with Normal Cytology Results Who Develop Grade 3 Cervical Intraepithelial Neoplasia

机译:GP5 + / 6 + -PCR和SPF10-Line印迹分析检测高危人类乳头瘤病毒的比较这些样本具有正常细胞学结果的妇女其发展为3级宫颈上皮内瘤变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Using a case control approach, we performed a two-way comparison study between GP5+/6+-PCR and HPV SPF10-Line Blot 25 (SPF10) assays for detection of 14 types of high-risk human papillomavirus (hrHPV) in samples from women with normal cytology results who had or developed grade 3 cervical intraepithelial neoplasia (CIN 3). Samples were pooled from two cohorts, i.e., women participating in population-based screening and women attending a gynecological outpatient clinic. Cases (n = 45) were women with histologically confirmed CIN 3 diagnosed within a median follow-up time of 2.7 (range, 0.2 to 7.9) years. Control samples were from women (n = 264) who had developed CIN 1 lesions at maximum (median follow-up at 5.8 [range, 0 to 10] years). Identical numbers of cases tested positive for 1 or more of the 14 hrHPV types by both systems (40/45; McNemar; P = 1.0). Conversely, SPF10 scored significantly more controls as hrHPV positive than did GP5+/6+-PCR (95/264 versus 29/264; McNemar; P < 0.001). Consequently, women with normal cytology results and an hrHPV GP5+/6+-PCR-positive test exhibited a risk of CIN 3 that was 4.5 times higher (odds ratio [OR], 65; 95% confidence interval [95%CI], 24 to 178) than that seen for women with an hrHPV-positive SPF10 test (OR, 14; 95%CI, 5 to 38)). Similar results were obtained after analysis of both cohorts separately. Discrepancy analysis by viral load assessment for the most common discordant hrHPV types (HPV16, -18, and -52) showed that samples which were SPF10 positive only for these types had viral loads significantly lower than those for samples that were positive by both assays (analysis of variance; P ≤ 0.006). Our data indicate that GP5+/6+-PCR has a better clinical performance than SPF10 for women who are diagnosed with CIN 3 after prior normal cytology results. The extra positivity scored by SPF10 mainly involved infections characterized by low viral loads that do not result in CIN 3.
机译:使用病例对照方法,我们进行了GP5 + / 6 + -PCR和HPV SPF10-Line Blot 25(SPF10)测定法之间的双向比较研究,以检测女性样品中的14种高危型人乳头瘤病毒(hrHPV)细胞学检查结果正常或已发生或发展为3级宫颈上皮内瘤变(CIN 3)的患者。从两个队列(即参加基于人群的筛查的妇女和妇科门诊的妇女)的样本中收集样本。病例(n = 45)是经组织学证实为CIN 3的女性,平均随访时间为2.7年(0.2至7.9年)。对照样本来自最大发展为CIN 1病变的女性(n = 264)(中位随访时间为5.8 [范围,0至10]年)。两个系统对14种hrHPV类型中的1种或多种测试为阳性的病例数相同(40/45; McNemar; P = 1.0)。相反,作为hrHPV阳性,SPF10得分比GP5 + / 6 + -PCR得分高得多(95/264对29/264; McNemar; P <0.001)。因此,细胞学检查结果正常且hrHPV GP5 + / 6 + -PCR阳性的女性,其CIN 3风险高4.5倍(几率[OR]为65; 95%置信区间[95%CI]为24)高于hrHPV阳性SPF10测试的女性(OR,14; 95%CI,5至38))。对两个队列分别进行分析后,获得了相似的结果。通过病毒载量评估对最常见的不一致hrHPV类型(HPV16,-18和-52)进行的差异分析显示,仅对这两种类型而言SPF10呈阳性的样品的病毒载量显着低于两种测定均呈阳性的样品(方差分析; P≤0.006)。我们的数据表明,对于先前经过正常细胞学检查后被诊断为CIN 3的女性,GP5 + / 6 + -PCR具有比SPF10更好的临床表现。 SPF10评分的额外阳性主要涉及病毒载量低且不会导致CIN 3的感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号